Keywords: amgen, 3rd-qtr, profit, plunges, 210m, back, esa

Amgen's 3rd-qtr 2007 profit plunges 82% to $210M on the back of US ESA restrictions

Article | 05 November 2007

Print This

World biotechnology major Amgen's third-quarter 2007 profit was hit by lower revenue from its portfolio of anemia drugs, after the US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in